NK cell-based immunotherapies: awakening the innate anti-cancer response

Fernando Souza-Fonseca-Guimaraes1

  • 1Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne VIC 3010, Australia and Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.

Discovery Medicine
|April 27, 2016
PubMed

Insights

Metastasis causes most cancer deaths, but therapies are limited. This review explores how natural killer (NK) cell immunotherapies can target cancer spread and improve patient outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Metastasis

Background:

  • Metastasis is the primary cause of cancer mortality, with limited effective treatments.
  • The immune system's role in cancer progression is increasingly recognized, yet its control over metastasis remains poorly understood.
  • Natural killer (NK) cells are key innate immune cells that eliminate transformed cells.

Purpose of the Study:

  • To review immunotherapies that modulate natural killer (NK) cell activity.
  • To explore the potential of NK cell-based strategies against cancer metastasis.

Main Methods:

  • Literature review of recent studies and clinical trials.
  • Analysis of NK cell mechanisms in tumor surveillance and elimination.
  • Overview of immunotherapeutic approaches targeting NK cell activation.

Main Results:

  • NK cells identify and induce death in tumor cells via abnormal receptor expression.
  • Modulating NK cell activation shows promise as a cancer immunotherapy.
  • NK cell-based strategies offer potential for combating disseminated cancer disease.

Conclusions:

  • NK cell immunotherapies represent a promising avenue for treating cancer metastasis.
  • Further research into NK cell modulation is crucial for developing effective anti-metastasis therapies.
  • Harnessing NK cell functions could overcome challenges in managing metastatic cancer.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
10.3K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
86.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.9K